Search

Your search keyword '"Carr T"' showing total 1,293 results

Search Constraints

Start Over You searched for: Author "Carr T" Remove constraint Author: "Carr T"
1,293 results on '"Carr T"'

Search Results

2. Implications of a regional resource adequacy program for utility integrated resource planning

3. Management strategies for preventing and recovering from bermudagrass winterkill.

6. Cutaneous and renal glomerular vasculopathy as a cause of acute kidney injury in dogs in the UK

7. Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

12. Delayed-mutual coupling dynamics of lasers: scaling laws and resonances

13. Negative-coupling resonances in pump-coupled lasers

16. Supplementary material from A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers

17. Supplementary Figures: Supplementary Figure 1.; Supplementary Figure 2.; Supplementary Tables: Supplementary Table 1.; Supplementary Table 2.; Supplementary Table 3.; Supplementary Table 4. from Circulating Biomarkers and Resistance to Endocrine Therapy in Metastatic Breast Cancers: Correlative Results from AZD9496 Oral SERD Phase I Trial

18. Supplementary Table 4 from A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers

31. An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice

35. Design and synthesis of potent and selective inhibitors of the osteoclast-specific cysteine protease, cathepsin K

36. Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO)

37. Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO)

39. Serial monitoring of genomic alterations in circulating tumor cells of ER‐positive/HER2‐negative advanced breast cancer: feasibility of precision oncology biomarker detection

40. Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer

49. Abstract 3143: Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: correlative study of AZD9496 oral SERD phase I trial

Catalog

Books, media, physical & digital resources